These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31179759)

  • 21. Lipid Nanoparticle Systems for Enabling Gene Therapies.
    Cullis PR; Hope MJ
    Mol Ther; 2017 Jul; 25(7):1467-1475. PubMed ID: 28412170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic application of chimeric RNA/DNA oligonucleotide based gene therapy.
    Lai LW; Lien YH
    Expert Opin Biol Ther; 2001 Jan; 1(1):41-7. PubMed ID: 11727546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent progress in gene therapy for inherited diseases.
    Wolfe JH
    Curr Opin Pediatr; 1994 Apr; 6(2):213-8. PubMed ID: 8032403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic medicine at the RNA level: modifications of the genetic repertoire for therapeutic purposes by pre-mRNA trans-splicing.
    Pergolizzi RG; Crystal RG
    C R Biol; 2004 Aug; 327(8):695-709. PubMed ID: 15506518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoscale platforms for messenger RNA delivery.
    Li B; Zhang X; Dong Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Mar; 11(2):e1530. PubMed ID: 29726120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmenting PBGD expression in the liver as a novel gene therapy for acute intermittent porphyria (AIPgene).
    Hum Gene Ther Clin Dev; 2014 Jun; 25(2):61-3. PubMed ID: 24933563
    [No Abstract]   [Full Text] [Related]  

  • 27. mRNA trans-splicing in gene therapy for genetic diseases.
    Berger A; Maire S; Gaillard MC; Sahel JA; Hantraye P; Bemelmans AP
    Wiley Interdiscip Rev RNA; 2016 Jul; 7(4):487-98. PubMed ID: 27018401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-related efficacy with an AAV vector in Fabry disease mice.
    Koeberl DD
    Mol Genet Metab; 2009 Mar; 96(3):83-4. PubMed ID: 19083254
    [No Abstract]   [Full Text] [Related]  

  • 29. Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes.
    Chandler RJ; Tsai MS; Dorko K; Sloan J; Korson M; Freeman R; Strom S; Venditti CP
    BMC Med Genet; 2007 Apr; 8():24. PubMed ID: 17470278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver-directed gene transfer and application to therapy.
    Sandig V; Strauss M
    J Mol Med (Berl); 1996 Apr; 74(4):205-12. PubMed ID: 8740651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic delivery of factor IX messenger RNA for protein replacement therapy.
    Ramaswamy S; Tonnu N; Tachikawa K; Limphong P; Vega JB; Karmali PP; Chivukula P; Verma IM
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):E1941-E1950. PubMed ID: 28202722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy for inherited metabolic diseases.
    Yilmaz BS; Gurung S; Perocheau D; Counsell J; Baruteau J
    J Mother Child; 2020 Nov; 24(2):53-64. PubMed ID: 33554501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Porphyrias: animal models and prospects for cellular and gene therapy.
    de Verneuil H; Ged C; Boulechfar S; Moreau-Gaudry F
    J Bioenerg Biomembr; 1995 Apr; 27(2):239-48. PubMed ID: 7592571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenoviral-mediated expression of porphobilinogen deaminase in liver restores the metabolic defect in a mouse model of acute intermittent porphyria.
    Johansson A; Nowak G; Möller C; Blomberg P; Harper P
    Mol Ther; 2004 Aug; 10(2):337-43. PubMed ID: 15294180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mRNA biotherapeutics landscape for rare genetic disorders.
    Iyer VR; P P; Kaduskar BD; Moharir SC; Mishra RK
    J Biosci; 2024; 49():. PubMed ID: 38383978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applications of lipid nanoparticles in gene therapy.
    Del Pozo-Rodríguez A; Solinís MÁ; Rodríguez-Gascón A
    Eur J Pharm Biopharm; 2016 Dec; 109():184-193. PubMed ID: 27789356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy for the lysosomal storage disorders.
    Cabrera-Salazar MA; Novelli E; Barranger JA
    Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene transfer to the liver.
    Glaser V
    Mol Med Today; 1996 Feb; 2(2):47. PubMed ID: 8796851
    [No Abstract]   [Full Text] [Related]  

  • 39. [Porphyrias and haem related disorders].
    Peoc'h K; Martin-Schmitt C; Talbi N; Deybach JC; Gouya L; Puy H
    Rev Med Interne; 2016 Mar; 37(3):173-85. PubMed ID: 26774916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The case for intrauterine gene therapy.
    Mattar CN; Waddington SN; Biswas A; Davidoff AM; Choolani M; Chan JK; Nathwani AC
    Best Pract Res Clin Obstet Gynaecol; 2012 Oct; 26(5):697-709. PubMed ID: 22819290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.